Healthcare >> CEO Interviews >> September 23, 1998
DR. CANDACE K. BRYAN, co-founded Kendle in 1981 with her husband and
business partner, Christopher Bergen. Kendle is an international
contract research organization that provides pharmaceutical and
biotechnology companies with quality clinical development services to
accelerate the drug development process. As CEO of Kendle, Dr. Bryan's
strategic direction has helped establish the company as a global leader
in the clinical development industry. In 1997, she successfully guided
the company through its initial public offering on The NASDAQ Stock
Market. The organization also became international with the acquisition
of two European contract research organizations ('CROs') and a U.S.
based CRO with interests in the Pacific Rim. Prior to founding Kendle,
Dr. Bryan held a number of academic positions, including adjunct
associate professor at the School of Pharmacy, University of Cincinnati
from 1982-1984; and clinical associate professor of pediatrics at the
University of Pennsylvania from 1979-1981. Dr. Bryan received her
doctorate in pharmacy from the University of Cincinnati and her
Epidemiology Fellowship at the University of North Carolina School of
Public Health. Dr. Bryan has published more that 15 scientific articles.
Dr. Bryan and her organization have been recognized for their
contributions to the community. She was recently selected as a 1998 YWCA
Career Woman of Achievement which recognizes women who are performing at
an outstanding level in their profession. In 1997 she received Ohio's
Rosabeth Moss Kanter Excellence in Enterprise Award and the 1996
Emerging Business Award from The Greater Cincinnati Chamber of Commerce.
Dr. Bryan is active in numerous business and community organizations.
She was recently elected as a director of the H.J. Heinz Company. She
currently serves as director of the Southwestern Ohio Chapter of the
March of Dimes, the Advisory Board of the University of Cincinnati
College of Business Administration, the Overture Awards, and as a
member of the Committee of 200 and the Cincinnati Contemporary Arts
Center Capital Campaign Cabinet. Profile
you anticipate in your sector of the health market over the next several
years?
Dr. Bryan: I think that pharmaceutical
